— Know what they know.
Not Investment Advice

PRGO NYSE

Perrigo Company plc
1W: -7.5% 1M: -1.6% 3M: +28.6% YTD: +4.9% 1Y: -35.2% 3Y: -49.8% 5Y: -61.0%
$14.26
+0.24 (+1.71%)
 
Weekly Expected Move ±7.0%
$12 $13 $14 $15 $16
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 47 · $2.0B mcap · 138M float · 2.36% daily turnover · Short 62% of daily vol

Cash Flow Trends

Operating Cash Flow
$238M -34.3% ▼
5Y CAGR: -17.8%
Capital Expenditures
$93M +21.0% ▲
5Y CAGR: -11.3%
Free Cash Flow
$145M -40.7% ▼
5Y CAGR: -20.8%
Dividends Paid
$159M -4.5% ▼
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$27M +85.9% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income-$69M-$131M-$13M-$172M-$1.4B
Depreciation & Amort.$312M$339M$360M$326M$338M
Stock-Based Comp.$60M$0$69M$64M$0
Change in Working Capital-$295M$20M-$58M-$75M-$101M
Other Non-Cash Items$139M$130M$155M$209M$1.5B
Operating Cash Flow$156M$307M$406M$363M$238M
— Investing Activities —
Capital Expenditures-$152M-$96M-$102M-$118M-$93M
Acquisitions (Net)$1.5B-$2.0B$0$0$0
Investment Purchases$0$0$0$0$0
Investment Sales$0$0$0$0$0
Other Investing-$64M$90M$24M$197M$18M
Investing Cash Flow$1.3B-$2.0B-$78M$79M-$75M
— Financing Activities —
Net Debt Issuance-$31M$584M-$30M-$438M-$35M
Stock Repurchased$0$0$0$0$0
Dividends Paid-$130M-$142M-$150M-$152M-$159M
Other Financing-$18M-$20M-$7M-$21M-$26M
Financing Cash Flow-$179M$422M-$187M-$611M-$220M
Net Change in Cash$1.2B-$1.3B$151M-$192M-$27M
Cash End of Period$1.9B$601M$751M$559M$532M
Free Cash Flow$4M$211M$304M$245M$145M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms